UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - selective+serotonin+reuptake+inhibitors+(ssris)
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Targeting Serotonin Transporter (SERT) for Cancer Immunotherapy (UCLA Case No. 2024-204)
UCLA researchers in the Department of Microbiology Immunology and Molecular Genetics have unveiled a novel therapeutic strategy utilizing SSRIs for solid cancer immunotherapy. BACKGROUND: Immunotherapy has become a highly effective method to combat cancer that enhances a patient’s immune system to attack tumors with high specificity. For instance,...
Published: 6/18/2024
|
Inventor(s):
Lili Yang
Keywords(s):
Cancer
,
Immune checkpoint blockade
,
immune checkpoint inhibitors
,
Immunotherapy
,
selective serotonin reuptake inhibitors (SSRIs)
,
serotonin
,
solid tumors
,
T Cell
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy